Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis

Y Zhang, C Zhang, J Shu, J Guo… - Human reproduction …, 2020 - academic.oup.com
ABSTRACT BACKGROUND Despite great advances in assisted reproductive technology,
poor ovarian response (POR) is still considered as one of the most challenging tasks in …

Management of poor responders in IVF: is there anything new?

F Ubaldi, A Vaiarelli, R D'Anna… - BioMed research …, 2014 - Wiley Online Library
Despite the fact that in the last two decades an enormous number of papers on the topic of
poor ovarian response have been published in the literature, so far it has been impossible to …

[HTML][HTML] Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech

RBF Leão, SC Esteves - Clinics, 2014 - SciELO Brasil
Gonadotropin therapy plays an integral role in ovarian stimulation for infertility treatments.
Efforts have been made over the last century to improve gonadotropin preparations …

[HTML][HTML] Accumulated Vitrified Embryos Could Be a Method for Increasing Pregnancy Rates in Patients with Poor Ovarian Response

J Shin, H Kwon, DH Choi, C Park, JH Kim… - Journal of Clinical …, 2022 - mdpi.com
We aimed to assess the efficacy of accumulated embryo transfer (ACC-ET) through several
controlled ovarian hyperstimulation (COS) cycles to increase the rates of pregnancy in …

Recombinant LH supplementation in patients with a relative reduction in LH levels during IVF/ICSI cycles: a prospective randomized controlled trial

R Lahoud, J Ryan, P Illingworth, F Quinn… - European Journal of …, 2017 - Elsevier
Purpose The aim of this study was to assess the use of recombinant luteinizing hormone
(rLH) supplementation in patients who experience a reduction in LH concentration during …

[HTML][HTML] Clinical outcomes following long GnRHa ovarian stimulation with highly purified human menopausal gonadotropin plus rFSH or rFSH in patients undergoing …

L Shu, Q Xu, Q Meng, X Dai, Y Zhang… - Annals of …, 2019 - ncbi.nlm.nih.gov
Background This clinical trial aimed to compare the clinical efficacy of highly purified human
menopausal gonadotropin (HP-HMG) plus recombinant human follicle-stimulating hormone …

[PDF][PDF] Poor responders in IVF–is there any evidence-based treatment for them?

I Szymusik, P Marianowski, A Zygula… - Neuroendocrinology …, 2015 - nel.altamira.sk
Despite the vast experience in controlled ovarian hyperstimulation, there are still women
who respond poorly to gonadotropins, which results in few oocytes at retrieval, reduced …

[HTML][HTML] A cohort study of both human menopausal gonadotropin (HMG) and recombinant luteinizing hormone addition at early follicular stage in in vitro fertilization …

X Xia, Y Shi, L Geng, D Liu, Z Hou, H Lin, R Li, H Wang… - Medicine, 2019 - journals.lww.com
A cohort study of both human menopausal gonadotropin (HMG) a... : Medicine A cohort study of
both human menopausal gonadotropin (HMG) and recombinant luteinizing hormone addition …

Diminished ovarian reserve and premature ovarian failure: A review

R Zangmo, N Singh, J Sharma - IVF Lite, 2016 - go.gale.com
Diminished ovarian reserve (DOR) is defined as reduced capacity of the ovaries to produce
oocytes; the oocytes produced are of poorer quality leading to the formation of poor quality …

[HTML][HTML] Ovarian stimulation in assisted reproductive technology cycles for varied patient profiles: An Indian perspective

PR Jirge, MM Patil, R Gutgutia, J Shah… - Journal of Human …, 2022 - journals.lww.com
Controlled ovarian stimulation has been an integral part of in vitro fertilisation (IVF) treatment
cycles. Availability of different gonadotropins for ovarian stimulation and gonadotropin …